Biodiversity controversies are captured within our Controversy Risk Assessment database. Data and analytics compiled by V.E, part of Moody’s ESG Solutions, captured 337 individual biodiversity allegations between December 2016 and April 2021. This represents 7% of the 5,097 controversies analysed over the same period. We expect the spotlight on the materiality and impact of biodiversity [...]
2020 was a year defined by social risks. The global pandemic, protests against inequality, workforce digitalisation and the social impacts of the energy transition are shifting the risk landscape for investors at an unprecedented rate. To help investors in navigating this context, the Moody’s ESG Solutions Group, through its affiliate V.E, provides daily ESG controversy [...]
V.E is constantly monitoring changes that impact the world of investing. Our analysts have put together a short briefing intended to keep you informed on the the latest in ESG. In December 2020, the UN Commission on Narcotic Drugs reclassified cannabis out of the most dangerous category of drugs, thus recognising its medicinal potential. In the [...]
